Approximately 397 units of 23 different Viatrexx sterile multi-dose medication vials are being recalled because they were manufactured in a way that cannot guarantee they are sterile. These products, which include varieties like Viatrexx-Connectissue, Viatrexx-MuSkel-Neural, and Viatrexx-Infla, are prescription-only (Rx) and were distributed to physicians for use. Using a medication that is not sterile can lead to serious, potentially life-threatening infections, especially when the product is administered via injection.
The manufacturing process failed to provide required assurance of sterility, meaning the vials may contain bacteria, fungi, or other contaminants. If these non-sterile products are injected or administered to patients, they can cause localized or systemic infections that may require medical intervention or hospitalization.
Contact healthcare provider and return product
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.